Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study.

Elisabeth B FjelltveitBjørn BlombergKanika KuwelkerFan ZhouTherese B OnyangoKarl A BrokstadRebecca ElyanowIan M KaplanCamilla TøndelKristin G I MohnTürküler ÖzgümüşRebecca J CoxNina Langelandnull null

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

This study documents a high burden of persisting symptoms after mild COVID-19, and suggest that infection induced SARS-CoV-2 specific immune responses may influence long-term symptoms.

Keyphrases

sars cov
respiratory syndrome coronavirus
immune response
coronavirus disease
sleep quality
high glucose
diabetic rats
risk factors
toll like receptor
drug induced
physical activity
inflammatory response
endothelial cells
stress induced